Peer Review reports
From: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations
| Original Submission | ||
|---|---|---|
| 8 May 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 15 Aug 2023 | Reviewed | Reviewer Report |
| 22 Aug 2023 | Reviewed | Reviewer Report - Maria Paparoupa |
| 18 Sep 2023 | Author responded | Author comments - Yanguo Liu |
| Resubmission - Version 3 | ||
| 18 Sep 2023 | Submitted | Manuscript version 3 |
| 21 Sep 2023 | Author responded | Author comments - Yanguo Liu |
| Resubmission - Version 4 | ||
| 21 Sep 2023 | Submitted | Manuscript version 4 |
| 22 Sep 2023 | Reviewed | Reviewer Report - Maria Paparoupa |
| 29 Sep 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 12 Oct 2023 | Editorially accepted | |
| 29 Nov 2023 | Article published | 10.1186/s12890-023-02707-x |
You can find further information about peer review here.